Levirate 500 Tablet contains Levetiracetam 500 mg, an antiepileptic medication primarily indicated for the treatment of partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, thereby reducing neuronal excitability and seizure propagation. This tablet is typically prescribed as adjunctive therapy in adults and pediatric patients aged four years and above. Levirate 500 is well-absorbed orally, with rapid onset of action and minimal hepatic metabolism, reducing the risk of drug interactions. Dosage should be individualized based on clinical response and tolerability, with careful titration to minimize adverse effects such as dizziness, somnolence, fatigue, and behavioral changes. Renal function assessment is recommended prior to initiation and during treatment, as dose adjustments may be necessary in patients with impaired renal clearance. Levirate 500 should be used under strict medical supervision, with regular monitoring to optimize therapeutic outcomes and ensure patient safety. It is contraindicated in individuals with known hypersensitivity to Levetiracetam or any tablet excipients. Patient adherence and education on potential side effects are essential for effective seizure control.